Hemoteq AG Information

Hemoteq is a leading contract development and manufacturing organization (CDMO) specializing in coatings for medical devices and components, with a particular focus on drug coatings for combination products. Hemoteq was acquired by Freudenberg Medical in 2015. In January 2026, the Hemoteq brand was fully integrated under Freudenberg Medical. Committed to a 360-degree approach from concept to series production, Freudenberg Medical reliably delivers customized solutions across core areas including coating design, product and process development, regulatory approval, and volume manufacturing. Based in Aachen, Germany, the company serves as a hub for strategic innovations at the interface of medical technology, pharmaceuticals, and biotechnology. The Hemoteq quality management system is certified to ISO 13485:2016 and approved under the Medical Device Single Audit Program (MDSAP).